As of April 18, 2025, AFYREN SAS (ALAFY.PA) has a market cap of $48.374 million USD. According to our data, AFYREN SAS is ranked No.8096 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $48.37 M |
-25.11%
|
Dec 31, 2024 | $64.59 M |
10.33%
|
Dec 29, 2023 | $58.55 M |
-65.78%
|
Dec 30, 2022 | $0.17 B |
-33.18%
|
Dec 31, 2021 | $0.26 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gevo
GEVO
|
$0.29 B |
-0.000 M
|
![]() USA
|
![]() Codexis
CDXS
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Green Plains
GPRE
|
$0.22 B |
0.000 M
|
![]() USA
|
![]() Aemetis
AMTX
|
$79.45 M |
0.000 M
|
![]() USA
|
![]() Cerevel Therapeutics
CERE
|
$8.19 B |
0.000 M
|
![]() USA
|
![]() Origin Materials
ORGN
|
$90.33 M |
0.060 M
|
![]() USA
|
![]() Ginkgo Bioworks
DNA
|
$0.46 B |
95.967 M
|
![]() USA
|
![]() Archer Daniels Midland (ADM)
ADM
|
$22.96 B |
0.000 M
|
![]() USA
|
Market Cap | = | ALAFY.PA Stock Price | * | ALAFY.PA Shares Outstanding |
= | $1.87 | * | 25.88 M | |
= | $48.37 M |